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Introduction
Pseudosarcomatous myofibroblastic proliferation (PMP)
of the bladder has been described by many. Roth1 first
described the lesion as a reactive pseudosarcomatous
response in 1980. In the past, these lesions have often
been initially misdiagnosed as malignancies such as
sarcomatoid urothelial carcinoma, leiomyosarcoma,
and rhabdomyosarcoma. The patient with PMP pres-
ents with symptoms that include urgency, urinary fre-
quency, dysuria and hematuria, urinary obstruction,
and pelvic pain.2 These tumors can occur at any age,
but are usually seen in young adults.3,4 PMP usually
appears as a polypoid or nodular, sometimes ulcer-
ated, exophytic mass with broad attachment to the
bladder wall.2,4 Treatment usually consists of trans-
urethral resection or partial cystectomy.4 PMP can
grow extensively through the muscularis propria to
invade the perivesicular adipose tissues, peritoneum, and
omentum.4 Recurrence has recently been reported in
3 cases,4 but it has not been reported to metasta-
size.4,5 We present a female with recurrent PMP of
the urinary bladder and review the literature.
Case Report
A 38-year-old woman had sudden onset of gross
hematuria for 1 day, and intravenous pyelography
showed a large filling defect on the lateral wall of the
urinary bladder (Figure 1). Cystoscopy showed a large
ovoid tumor on the left lateral wall of the urinary
bladder near the left ureteral orifice. Then, abdominal
computed tomography was arranged and disclosed a
5.6 ×3.5-cm mass lesion on the left posterior wall 
of the urinary bladder with muscle layer invasion, but
no lymph node lesion was noted (Figure 2). Initially,
urothelial carcinoma or tumor of other pathology was
suspected. Transurethral resection of bladder tumor
(TURBT) was performed, and pathology disclosed a
picture of spindle cell proliferation in the submucosal
and mucosal layers of the urinary bladder. The cellular
proliferation was associated with mild nuclear atypia
and eosinophilic cytoplasm within a fibrillary or myxoid
background (Figure 3). It was compatible with PMP.
Cystoscopy was performed again 2 months later
due to gross hematuria. Local recurrence was found
(Figure 4), and TURBT was performed again. The
CASE REPORT
Pseudosarcomatous Myofibroblastic Proliferation
of the Urinary Bladder
Chi-Hao Hsiao1, Yu-Ching Wen1,2*, Liang-Ming Lee1,2
1Department of Urology, Taipei Medical University-Municipal Wan Fang Hospital, and 2Department of Urology, 
Taipei Medical University School of Medicine, Taipei, Taiwan, R.O.C.
Pseudosarcomatous myofibroblastic proliferation (PMP) of the bladder is a rare, benign, and proliferative lesion of the
submucosal stroma. We report a 38-year-old female patient who was initially diagnosed with urothelial carcinoma of the
urinary bladder under intravenous pyelography. Bladder tumor was resected by the transurethral method, and pathology
disclosed a picture compatible with pseudosarcomatous myofibroblastic proliferation. However, local recurrence was
found 2 months later, and tumor resection was performed again. The patient has been followed-up at our outpatient
department for a year without any evidence of recurrence. [J Chin Med Assoc 2008;71(8):431–434]
Key Words: pseudosarcomatous myofibroblastic proliferation, urinary bladder
© 2008 Elsevier. All rights reserved.
*Correspondence to: Dr Yu-Ching Wen, Division of Urology, Department of Surgery, Taipei Medical
University-Municipal Wan Fang Hospital, 111, Section 3, Shin-Long Road, Taipei 116, Taiwan, R.O.C.
E-mail: s811007@yahoo.com.tw ● Received: November 1, 2007 ● Accepted: April 8, 2008
J Chin Med Assoc • August 2008 • Vol 71 • No 8432
C.H. Hsiao, et al
Figure 1. Intravenous pyelography revealed an ovoid large filling
defect on the left lateral wall of the urinary bladder.
Figure 2. Computed tomography showed a 5.6 ×3.5-cm mass
lesion on the lateral posterior wall of the urinary bladder.
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Figure 3. (A) Spindle cell proliferation in the submucosa and mucosa with mild nuclear atypia and eosinophilic cytoplasm within fibril-
lary or myxoid background was observed (hematoxylin & eosin, 100×). The cells were weakly positive for: (B) cytokeratin and (C)
smooth muscle actin. (D) The tumor did not involve the muscle layer (arrow).
patient has been followed-up at our outpatient depart-
ment, with no evidence of recurrence for 1 year.
Discussion
PMP of the urinary bladder was first reported by Roth
in 1980.1 He described a 32-year-old woman with
recurrent cystitis and hematuria associated with an
ulcerated bladder lesion. Unique histologic features
included tumor-like, atypical spindle cell proliferation.
Histology and etiology were not defined in Roth’s
report, although chronic cystitis was characteristic in
the history.
In subsequent years, many descriptive names have
been used to describe histologically similar lesions,
including inflammatory pseudotumor, nodular fasci-
itis, postoperative spindle cell nodule, pseudosarco-
matous fibromyxoid tumor, PMP, and inflammatory
myofibroblastic tumor. Unfortunately, no consensus
on nomenclature seems imminent.4
Recent reports show a male predominance (3:1),
with a mean patient age range at presentation of 47 to
54 years (range, 3–89 years).4,6 Hematuria is the most
common presenting symptom (60%), and our case had
the same presenting symptom. The following symp-
toms, pelvic pain (7%), mass lesion (7%), obstructive
symptoms (4%) and urinary tract infection (4%) were
often noted. Prior instrumentation was reported in
17–21% of cases, and a feature that led investigators
to propose at least 2 categories of such lesions was
separated chiefly on the basis of whether or not the
onset of the lesion was preceded by previous instru-
mentation.4 However, such a separation may be invalid.
Most cases are limited to the bladder, although concur-
rent involvement of the prostate has been reported.4,6
Lesions range in size from 1 cm to 12 cm, and are
polypoid or nodular, with variable degrees of mucosal
hemorrhage and ulceration. The cut surface is gray-
white to tan-pink and often gelatinous. Microscopically,
the lesions vary from highly myxoid to highly cellular,
and are composed of bland, spindle-shaped myofi-
broblastic cells, with an associated interlacing vascular
network and a variable but polymorphous inflamma-
tory infiltrate. Mitotic rates range from 0 to 20 per 10
high-power field. Invasion into the muscularis mucosa
and muscularis propria is common, and infrequently
the process may involve perivesical adipose tissue,
peritoneum or even omentum. Necrosis, if present, is
usually focal and associated with surface ulceration or
deep muscularis propria invasion. Immunohistochemi-
cally, the spindle cells have expression for epithelial
markers such as cytokeratin AE1/3 (94%), and smooth
muscle markers such as smooth muscle actin (68%)
and desmin (60%).4,6
Transurethral resection or partial cystectomy has
been reported as the treatment of choice.7
Whether these lesions are reactive or neoplastic is
unresolved. It has been shown recently that a t(2;5)
involving the Alk-1 gene can be demonstrated by flu-
orescent in situ hybridization in a substantial number
of cases with expression of Alk-1 protein by immuno-
histochemistry, supporting the notion that a significant
proportion of these histologically similar lesions are
truly neoplastic, while the remainder may be either
reactive or harbor a different genetic derangement.6
Most lesions can be managed by transurethral resec-
tion, although more extensive resection is sometimes
required. Cases regarded as “typical” occasionally recur
locally but do not metastasize.4,6
Iczkowski et al5 reported the death of 1 patient
who was not a candidate for definitive tumor ablation
after transurethral resection of a 13-cm tumor. The
tumor grew to 37.5 cm, resulting in urinary obstruc-
tion and urosepsis. Sandhu and Iacovou7 reported the
case of a patient with full-thickness bladder invasion
and tumor fixation to the rectus sheath who was
treated with 4 months of oral antibiotics. They saw
resolution of the lesion at 9 months of follow-up, and
the patient was free of recurrence after 3 years.7
PMP of the urinary bladder has unique clinical and
pathologic features that allow their distinction from
primary bladder sarcoma and sarcomatoid carcinoma.8
The definition of PMP and inflammatory myofibro-
blastic tumor of the urinary bladder is still controver-
sial because of the malignant potential.9 Transurethral
resection or partial cystectomy is sufficient to eradicate
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Figure 4. A large ovoid tumor (2.5 ×2.5 cm) on the left lateral wall
of the urinary bladder was seen under cystoscopy.
these lesions, with few patients requiring further addi-
tional resection. Further research is needed to establish
a correct diagnosis among these lesions, which have
varying biological potential with important therapeutic
and prognostic implications.
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